Patent expiry and biosimilars: difference between revisions
Diff·revision 17 → 18·10:49, 8 Sep 2025
Difference between revision 17 and revision 18 of Patent expiry and biosimilars. This revision changed no lines of source — the edit was a null or whitespace change.
| Revision 17 — 06:49, 21 Aug 2025 LabRangeLindy (talk) clarify that personal importation and commercial importation are different questions 4,183 bytes ±0 | Revision 18 — 10:49, 8 Sep 2025 Chromatokid (talk) state that the position differs between jurisdictions and give two examples 4,183 bytes ±0 | ||
|---|---|---|---|
| — | No change to the page source. | — |